Nivolumab (anti-PD-1)Nivolumab (anti-PD-1)
Move your mouse over image or click to enlarge

Nivolumab (anti-PD-1)

Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities. MW : 143.597 KD.
Cat# Size Price Qty Buy
A2002-5mg 5mg £579.00

Additional Information

Property Value or Rating
Product Size 5mg
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2002

Related Documents